TiffiniSmithVossMD

Neurology • Charlottesville, VA

Movement Disorder, Neurodegenerative

VP, Clinical Development at PassageBio

Join to view full profile

Dr. Voss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Voss' full profile

Already have an account?

Office
Lee St
Ground floor
Charlottesville, VA 22908
Phone+1 434-924-5542

Fax+1 434-982-1064

Education & Training

University of Pennsylvania Health SystemResidency, Neurology, 2004 - 2007
University of Pennsylvania Health SystemInternship, Internal Medicine, 2003 - 2004
Perelman School of Medicine at the University of PennsylvaniaClass of 2003

Certifications & Licensure

VA State Medical License 2009 - 2026
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Safety and Efficacy of Rasagiline in Restless Legs Syndrome Start of enrollment: 2010 Sep 01
Terminated
Phase 2, Phase 3

Publications & Presentations

PubMed

4 citations
Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial.
Yuki Mukai, Robert Lupinacci, Stephen Marder, Linda Snow-Adami, Tiffini Voss
Schizophrenia Research. 2024-08-01
2 citations
Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.
Tiffini Voss, James Kost, Swati Pal Mercer, Christine Furtek, Christopher Randolph
Journal of Alzheimer's Disease. 2023-01-01
An Exploratory Study Using Electronic Medical Records to Assess the Feasibility of Establishing Cohorts of Patients with Genetic Causes of Parkinson's Disease.
Susan J Lee, Peter M Shaw, Bob Thornton, Amit Kumar, Michal Eizik
Journal of Parkinson's Disease. 2022-01-01